Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Noriko Matsunaga
Efficacy and Safety of Sunitinib Alternate Day Regimen in Patients With Metastatic Renal Cell Carcinoma in Japan: Comparison With Standard 4/2 Schedule
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Related publications
Improved Long-Term Clinical Outcomes and Safety Profile of Sunitinib Dosing Schedule With 4/2 Switched to 2/1 in Patients With Metastatic Renal Cell Carcinoma
Journal of Cancer
Oncology
Sunitinib-Associated Hypertension and Neutropenia as Efficacy Biomarkers in Metastatic Renal Cell Carcinoma Patients
British Journal of Cancer
Cancer Research
Oncology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma
European Urology
Urology
Association of Angiopoietin-2 and Ki-67 Expression With Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma
PLoS ONE
Multidisciplinary
Reversible Myocardial Dysfunction in a Young Woman With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
